← Open Payments lookup

DEAN SOLOMON: Open Payments

NPI 1588641641 · RANDOLPH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$889 in 45 payments from 11 companies in 2025. Trend: 2023 $749 · 2024 $654 · 2025 $889

Food & beverage: $889
CompanyPaymentsAmount
ABBVIE INC.10$179
E.R. Squibb & Sons, L.L.C.5$115
Teva Pharmaceuticals USA, Inc.5$115
Lundbeck LLC5$112
Neurocrine BioSciences, Inc.5$97
Otsuka America Pharmaceutical, Inc.5$93
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$64
Janssen Pharmaceuticals, Inc2$39
Takeda Pharmaceuticals U.S.A., Inc.2$32
Vanda Pharmaceuticals Inc.2$29

Products named: VRAYLAR, REXULTI, COBENFY, INGREZZA, AUSTEDO XR, CAPLYTA, ABILIFY MAINTENA, TRINTELLIX.

Industry payments across MA — which companies pay providers there.